mTOR-Inhibition Neue Standardtherapie?

Best Practice Onkologie - Germany
doi 10.1007/s11654-013-0017-5
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

Springer Science and Business Media LLC

Related search

Studie Bestätigt Therapieerfolg Durch mTOR-Inhibition

Info Onkologie
2012English

Honokiol-Mediated Inhibition of PI3K/mTOR Pathway

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2009English

Inhibition of mTOR Induces a Paused Pluripotent State

Nature
Multidisciplinary
2016English

Dual PI3K/mTOR Inhibition in Colorectal Cancers withAPCandPIK3CAMutations

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2016English

mTOR Inhibition: From Aging to Autism and Beyond

Scientifica
AgriculturalEnvironmental ScienceBiological Sciences
2013English

mTOR Inhibition Remodels Extracellular Matrix Components of Human Osteoarthritic Cartilage

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2016English

Dual Inhibition of ULK1 and mTOR Enhances Tumor Cell Apoptosis

Cancer Discovery
Oncology
2015English

AXL Circumvents PI3K Inhibition by Activating EGFR-PKC-mTOR Signaling

Cancer Discovery
Oncology
2015English

Mammalian Target of Rapamycin (mTOR) Inhibition in Advanced Bronchial Carcinoids

European Oncology and Haematology
OncologyHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy